Profluent Bio raises $106M from Jeff Bezos and others to accelerate protein design with AI
PositiveArtificial Intelligence
- Profluent Bio Inc. has successfully raised $106 million in funding, with notable contributions from Jeff Bezos and other investors, to enhance its efforts in making biological processes more programmable through artificial intelligence. This investment marks Bezos's third venture capital engagement in AI startups this week.
- The funding is crucial for Profluent Bio as it seeks to innovate in protein design, which could lead to significant advancements in biotechnology and healthcare, potentially transforming how biological systems are engineered and utilized.
- This development reflects a growing trend in the tech industry where major investors, including Bezos, are increasingly backing AI initiatives that promise to revolutionize various sectors, from industrial applications to healthcare, highlighting a robust interest in the intersection of AI and biology.
— via World Pulse Now AI Editorial System
